Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Pharmacodynamic Effect of a 6-week Treatment With Triamcinolone Acetonide Aqueous Nasal Spray 110 microg and 220 microg Once Daily on Basal Hypothalamic-Pituitary-Adrenal (HPA) Axis Function in Children [2 to <12 Years of Age] With Allergic Rhinitis (AR).

Next Previous
Trial Profile

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Pharmacodynamic Effect of a 6-week Treatment With Triamcinolone Acetonide Aqueous Nasal Spray 110 microg and 220 microg Once Daily on Basal Hypothalamic-Pituitary-Adrenal (HPA) Axis Function in Children [2 to <12 Years of Age] With Allergic Rhinitis (AR).

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Pharmacodynamics
  • Sponsors Sanofi

Most Recent Events

  • 08 Nov 2011 Results presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology.
  • 28 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 28 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top